News

Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.   

Paul Peter Tak named to PharmaVoice’s 100 List

https://www.pharmavoice.com/digital-edition/july-august-2021/#62

Looking forward to presenting an overview of Candel Therapeutics at the upcoming Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 1:30 PM ET.

https://www.businesswire.com/news/home/20210527005135/en/Candel-Therapeutics-to-Present-at-Upcoming-Jefferies-Virtual-Healthcare-Conference

Prof Paul Peter Tak: Rheumatology, Real Impact and Comfort Zones

Prof Paul Peter Tak is my guest on the podcast this week. He talks to me about growing up in the Netherlands. his medical career and how he ended up specializing in Rheumatology. We chat about his i…

The Story of Flagship Pioneering and The Future of Medicines

James is joined by Dr. Paul-Peter Tak, Venture Partner at Flagship Pioneering and CEO of Kintai Therapeutics. Over a more than 25-year career in the life sciences, Paul-Peter has created and le…

Careers in Discovery

Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influen…

Listen Notes: Paul-Peter Tak, Academic, business leader and biotech entrepreneur

In this episode, Paul-Peter Tak joins Monica Westley to discuss his innovative ideas within the type 1 diabetes space and how immunology can play a role in helping find a cure for T1D. Paul-Peter is…

Podomatic: Paul-Peter Tak

In biotech, DR. PAUL-PETER TAK, the CEO of Kintai Therapeutics gives us a bigger picture of our gut – it’s not just your microbiome that plays a significant role in the recovery from illness. Lis…

BIOS APPOINTS BIOTECH LEADER PAUL PETER TAK, MD PHD, AS A STRATEGIC ADVISOR

Cambridge, UK and Montreal, Canada – 5 May, 2021 – BIOS Health, a pioneer in the development of neural interfaces, has appointed world-renowned immunologist and biotechnology business leader, Paul P…

GSK Funds a New Startup with Immunometabolic Focus

Backed by GlaxoSmithKline and Boston’s SV Health Investors, a new biopharmaceutical company known as Sitryx launched with $30 million in a Series A funding round to develop disea…

EXCLUSIVE: Flagship Pioneering Company Kintai Therapeutics Focuses on Enteric Therapeutics

The vast majority of immune cells are found in the gut but historically, the gut has been viewed as a liability to drug development. The question of whether or not greater understanding of harnessin…
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.